BBI’s Dr. Colin Pritchard believes that to chart the future of precision medicine, one needs…
dcorriganJuly 6, 2022
ARCH Venture Partners has closed a $2.975 billion fund targeted for early-stage biotech companies. The firm’s…
dcorriganJuly 6, 2022
Dr. Abby R. Rosenberg, director of the Palliative Care and Resilience (PCAR) lab at the…
dcorriganJuly 5, 2022
Three Seattle biotech companies are joining forces to support open-access development of protein folding and…
dcorriganJuly 5, 2022
Dr. Timothy H. Dellit today began serving as interim CEO of the UW Medicine healthcare…
dcorriganJuly 5, 2022
The Brotman Baty Institute was recently joined by BBI Member Dr. Manu Setty, assistant professor…
dcorriganJuly 1, 2022
With a promising approach to drive brain repair and recovery following a stroke, University of…
dcorriganJuly 1, 2022
The authors evaluate the efficacy of guselkumab for the treatment of active psoriatic arthritis (PsA)…
dcorriganJuly 1, 2022
The Burroughs Wellcome Fund’s Board of Directors is pleased to announce the 2022 award recipients…
dcorriganJune 30, 2022
